Evaxion A/S Statistics
NASDAQ: EVAXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.05-0.09 (-2.87%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Evaxion A/S by the numbers
Evaxion A/S has a market capitalization of $27.5 million based on 9.02M shares outstanding. With trailing EPS of $-1.00, Evaxion A/S is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.7% below its 50-day average and 16.5% below its 200-day average.
Average daily trading volume is 199.49K shares, or about $608,441 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EVAX valuation vs. peer median
| Metric | EVAX | Peer median | Difference |
|---|---|---|---|
| Market cap | $27.52M | $33.70M | -18% |
| Avg. volume | 199.49K | 123.58K | +61% |
Peer median across 8 companies: QNCX, ATYR, ALGS, GNTA, CVM, SCLX, ELUT, MGX.
Valuation
- Market cap
- $27.52M
- EPS (TTM)
- $-1.00
- Shares outstanding
- 9.02M
Price and trading
- Previous close
- 3.14
- Open
- 3.18
- Day range
- 3.02 – 3.23
- 52-week range
- 2.77 – 12.15
- 52-week change
- -44.76%
- Beta
- —
- Volume
- 63.97K
- Average volume
- 199.49K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 27.52M
- Forward Pe
- -203.33
- Eps
- -1.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.15
- Week52 Low
- 2.77
- Avg Volume
- 199.49K
- Shares Outstanding
- 9.02M
- Ma50
- 3.14
- Ma200
- 3.65
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -74.90%
- Pct From52w Low
- 10.11%